These regimens offer effective palliation, with the choice influenced by patient and disease factors, including prognosis and ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Metastasis remains the primary challenge to ... The new tumor is still colorectal cancer (not brain, liver, or bone cancer), yet the cells in the new tumor are also radically different from ...

The new occurrences of cancer are called metastases. A phenotypic study to examine the distinct morphologies of ER+ and ER− breast cancer bone metastases focusing on the mechanism associated ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

or bone cancer), yet the cells in the new tumor are also radically different from those in the tumor where the cancer started. And the differences between the two are critical. Dr. Karuna Ganesh ...